Signaturefd LLC Has $114,000 Holdings in Acadia Healthcare Company, Inc. $ACHC

Signaturefd LLC boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 1,451.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,043 shares of the company’s stock after acquiring an additional 4,718 shares during the period. Signaturefd LLC’s holdings in Acadia Healthcare were worth $114,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Public Employees Retirement System of Ohio lifted its position in Acadia Healthcare by 2.6% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 30,468 shares of the company’s stock valued at $691,000 after acquiring an additional 760 shares in the last quarter. Counterpoint Mutual Funds LLC bought a new stake in shares of Acadia Healthcare in the second quarter valued at about $736,000. Parallel Advisors LLC boosted its position in shares of Acadia Healthcare by 1,120.3% during the second quarter. Parallel Advisors LLC now owns 5,174 shares of the company’s stock worth $117,000 after buying an additional 4,750 shares during the period. Inspire Investing LLC grew its holdings in shares of Acadia Healthcare by 9.0% during the first quarter. Inspire Investing LLC now owns 11,174 shares of the company’s stock worth $339,000 after buying an additional 925 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after buying an additional 27,207 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Barclays decreased their target price on shares of Acadia Healthcare from $28.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, August 7th. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Sunday, August 3rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a research note on Saturday, September 27th. Finally, UBS Group lowered their target price on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Eight equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $39.36.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $27.14 on Friday. Acadia Healthcare Company, Inc. has a one year low of $17.13 and a one year high of $60.52. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $2.51 billion, a price-to-earnings ratio of 17.97, a PEG ratio of 5.34 and a beta of 0.90. The firm has a 50 day simple moving average of $22.26 and a 200 day simple moving average of $23.49.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period in the prior year, the business earned $0.91 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.